The discovery and optimisation of pyrido[2,3-d]pyrimidine-2,4-diamines as potent and selective inhibitors of mTOR kinase

被引：76

作者：

Malagu, Karine ^{[2
]}

Duggan, Heather ^{[2
]}

Menear, Keith ^{[2
]}

Hummersone, Marc ^{[2
]}

Gomez, Sylvie ^{[2
]}

Bailey, Christine ^{[2
]}

Edwards, Peter ^{[2
]}

Drzewiecki, Jan ^{[2
]}

Leroux, Frederic ^{[2
]}

Quesada, Mar Jimenez ^{[2
]}

Hermann, Gesine ^{[2
]}

Maine, Stephanie ^{[2
]}

Molyneaux, Carrie-Anne ^{[2
]}

Le Gall, Armelle ^{[2
]}

Pullen, James ^{[2
]}

Hickson, Ian ^{[2
]}

Smith, Lisa ^{[2
]}

Maguire, Sharon ^{[2
]}

Martin, Niall ^{[2
]}

Smith, Graeme ^{[1
,2
]}

Pass, Martin ^{[1
]}

机构：

[1] AstraZeneca, Macclesfield SK10 4TG, Cheshire, England

[2] KuDOS Pharmaceut Ltd, Cambridge 3B4 0WG, England

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2009年 / 19卷 / 20期

关键词：

Antitumour; mTOR; Serine/threonine kinase; SIGNALING FUNCTIONS; MAMMALIAN PROTEIN; RAPAMYCIN; TARGET; WORTMANNIN; LY294002; PATHWAY; S6K1;

D O I：

10.1016/j.bmcl.2009.08.038

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

We describe a novel series of potent inhibitors of the kinase activity of mTOR. The compounds display good selectivity relative to other PI3K-related kinase family members and, in cellular assays, inhibit both mTORC1 and mTORC2 complexes and exhibit good antiproliferative activity. (C) 2009 Elsevier Ltd. All rights reserved.

引用

页码：5950 / 5953

页数：4

共 30 条

[1] Discovery of novel pyrrolo [2,3-d] pyrimidine derivatives as potent FAK inhibitors based on cyclization strategy
Zeng, Shenxin
Yuan, Shuai
Zhang, Yu
Du, Jinbei
Wu, Yuhao
Chen, Yinqiao
Zhu, Peizhen
Huang, Wenhai
BIOORGANIC CHEMISTRY, 2023, 139
[2] Discovery of Potent and Selective Inhibitors of the Mammalian Target of Rapamycin (mTOR) Kinase
Nowak, Pawel
Cole, Derek C.
Brooijmans, Natasja
Bursavich, Matthew G.
Curran, Kevin J.
Ellingboe, John W.
Gibbons, James J.
Hollander, Irwin
Hu, YongBo
Kaplan, Joshua
Malwitz, David J.
Toral-Barza, Lourdes
Verheijen, Jeroen C.
Zask, Arie
Zhang, Wei-Guo
Yu, Ker
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (22) : 7081 - 7089
[3] Synthesis and structure-activity relationships of PI3K/mTOR dual inhibitors from a series of 2-amino-4-methylpyrido[2,3-d]pyrimidine derivatives
Han, Fangbin
Lin, Songwen
Liu, Peng
Tao, Jing
Yi, Chongqin
Xu, Heng
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (18) : 4538 - 4541
[4] Discovery and Biological evaluation of pyrimido[4,5-d] pyrimidine-2,4(1H, 3H)-dione derivatives as potent Bruton's tyrosine kinase inhibitors
Diao, Yanyan
Fang, Xiaoyu
Song, Peiran
Lai, Mengzhen
Tong, Linjiang
Hao, Yongjia
Dou, Dou
Liu, Yingqiang
Ding, Jian
Zhao, Zhenjiang
Xie, Hua
Li, Honglin
BIOORGANIC & MEDICINAL CHEMISTRY, 2019, 27 (15) : 3390 - 3395
[5] Synthesis and antitumour activity of certain pyrido[2,3-d] pyrimidine and 1,8-naphthyridine derivatives
Elansary, Afaf K.
Moneer, Ashraf A.
Kadry, Hanan H.
Gedawy, Ehab M.
JOURNAL OF CHEMICAL RESEARCH, 2014, (03) : 147 - 153
[6] Discovery and Characterization of the Potent and Highly Selective (Piperidin-4-yl)pyrido[3,2-d]pyrimidine Based in Vitro Probe BAY-885 for the Kinase ERK5
Duy Nguyen
Lemos, Clara
Wortmann, Lars
Eis, Knut
Holton, Simon J.
Boemer, Ulf
Moosmayer, Dieter
Eberspaecher, Uwe
Weiske, Joerg
Lechner, Christian
Prechtl, Stefan
Suelzle, Detlev
Siegel, Franziska
Prinz, Florian
Lesche, Ralf
Nicke, Barbara
Nowak-Reppel, Katrin
Himmel, Herbert
Mumberg, Dominik
von Nussbaum, Franz
Nising, Carl F.
Bauser, Marcus
Haegebarth, Andrea
JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (02) : 928 - 940
[7] Identification of Thieno[3,2-d]pyrimidine derivatives as potent and selective Janus Kinase 1 inhibitors
Kim, Younghoon
Jeon, Eunhye
Ahn, Hyunwoo
Kang, Juhee
Sim, Taebo
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 286
[8] Discovery and optimization of thieno[2,3-d]pyrimidines as B-Raf inhibitors
Packard, Garrick K.
Papa, Patrick
Riggs, Jennifer R.
Erdman, Paul
Tehrani, Lida
Robinson, Dale
Harris, Roy
Shevlin, Graziella
Perrin-Ninkovic, Sophie
Hilgraf, Robert
McCarrick, Margaret A.
Tam Tran
Fleming, Yuedi
Bai, April
Richardson, Samantha
Katz, Jason
Tang, Yang
Leisten, Jim
Moghaddam, Mehran
Cathers, Brian
Zhu, Dan
Sakata, Steven
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (01) : 747 - 752
[9] Discovery of 4-(Piperazin-1-yl)-7H-pyrrolo[2,3-d]pyrimidine Derivatives as Akt Inhibitors
Liu, Yang
Yin, Yanzhen
Zhang, Jingya
Nomie, Krystle
Zhang, Liang
Yang, Dezhi
Wang, Michael L.
Zhao, Guisen
ARCHIV DER PHARMAZIE, 2016, 349 (05) : 356 - 362
[10] Discovery of 2-ureidophenyltriazines bearing bridged morpholines as potent and selective ATP-competitive mTOR inhibitors
Zask, Arie
Verheijen, Jeroen C.
Richard, David J.
Kaplan, Joshua
Curran, Kevin
Toral-Barza, Lourdes
Lucas, Judy
Hollander, Irwin
Yu, Ker
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (08) : 2644 - 2647

← 1 2 3 →